Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.

about

Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.

P2860

Q36427037-A94F86B2-D6C3-48FC-B836-64721165F85C

P2860

Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.

Item

http://www.wikidata.org/entity/Q41890760

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Multiparametric PET/CT-perfusi ...... compared with standard PET/CT.

@en

type

Item

label

Multiparametric PET/CT-perfusi ...... compared with standard PET/CT.

@en

prefLabel

Multiparametric PET/CT-perfusi ...... compared with standard PET/CT.

@en

P1476

Multiparametric PET/CT-perfusi ...... compared with standard PET/CT.

@en

P2093

Chantal Pauli

http://www.w3.org/2001/XMLSchema#string

Joachim Diebold

http://www.w3.org/2001/XMLSchema#string

Klaus Strobel

http://www.w3.org/2001/XMLSchema#string

Martin W Huellner

http://www.w3.org/2001/XMLSchema#string

Patrick Veit-Haibach

http://www.w3.org/2001/XMLSchema#string

Philipp Gut

http://www.w3.org/2001/XMLSchema#string

Ralph Winterhalder

http://www.w3.org/2001/XMLSchema#string

Timothy D Collen

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Reduced lung-cancer mortality with low-dose computed tomographic screening

Role of smoking in global and regional cancer epidemiology: current patterns and data needs.

Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density.

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.

Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.

P2888

2191-219x-4-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2191-219X-4-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Burkhardt Seifert

P577

2014-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035071135

http://www.w3.org/2001/XMLSchema#string

P698

24450990

http://www.w3.org/2001/XMLSchema#string

P932

3901766

http://www.w3.org/2001/XMLSchema#string

Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.

about

P2860

P2860

Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932